MetaCap

Cytosorbents (CTSO) vs Modular Medical (MODD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Cytosorbents (CTSO) has outperformed Modular Medical (MODD) over the past year, losing 70.6% versus a loss of 87.4%. Modular Medical is the larger company by market cap ($16.4 million vs $13.1 million), about 1.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CTSO-70.58%MODD-87.39%
+24%-36%-96%
Nov 21, 20251 yearNov 20, 2026
CTSO-94.45%MODD-98.69%
+31%-37%-105%
Feb 7, 20225 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CTSO versus MODD key metrics
MetricCTSOMODD
Share price$4.16$1.68
Market cap$13.12M$16.36M
1-day change-18.91%-11.81%
YTD return-67.45%-84.62%
1-year return-70.58%-87.39%
5-year return-95.62%—
EPS (TTM)$-5.62$-6.59
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$37.06M—
Revenue growth (YoY)+4.12%—
Net income (latest FY)$-8.20M$-28.24M
Gross margin71.48%—
Operating margin-39.79%—
Net margin-22.12%—
52-week high$17.00$16.20
52-week low$2.84$1.20
Distance from 52-week high-75.53%-89.63%
Analyst consensusnone—
Avg. price target upside+1041.83%—
Average volume37.34K171.63K
Shares outstanding3.15M9.74M
Employees12951
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • CTSO has outperformed MODD by 16.8 percentage points over the past year.

About Cytosorbents

CTSO stock →

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform in the United States, Germany, and internationally. Its flagship product, CytoSorb, is an extracorporeal blood purification cartridge to reduce cytokine storms in common critical illnesses, bilirubin in liver failure, myoglobin in trauma and critical illnesses, and inflammatory mediators and blood thinners in cardiac surgery applications, as well as to remove antithrombotic drugs and inflammatory mediators in cardiothoracic surgery applications.

Health Care · Medical/Dental Instruments · 129 employees

About Modular Medical

MODD stock →

Modular Medical, Inc. operates as a medical device company.

Health Care · Medical/Dental Instruments · 51 employees

CTSO vs MODD FAQ

Which is bigger, Cytosorbents or Modular Medical?

Modular Medical (MODD) is larger, with a market capitalization of $16.36M compared with $13.12M for Cytosorbents (CTSO).

Which stock has performed better over the past year, CTSO or MODD?

CTSO returned -70.58% over the past 12 months, compared with -87.39% for MODD (price return, excluding dividends). Past performance does not predict future results.

Are Cytosorbents and Modular Medical in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons